Newsletter: Weekly FDA Review (11/12/2009) - Subscribe/Unsubscribe
- Final Approvals (6)
- Rejections (0)
- Orphan Drug Designations (2)
- Recommended Approvals (0)
- Fast Track Status (0)
- Complete Response Letters (0)
- Tentative Approvals (0)
- Priority Reviews (0)
- New Drug Applications (3)
- Alerts, Recalls and Shortages (1)
Sentri7 monitors anticoagulation patients to help you comply with The Joint Commission's NPSG 3E. Get a demo.
1. Final Approvals
- Glaxo wins U.S. approval for swine flu vaccine
Reuters - Teva Receives Final Approval For Generic Prevacid Delayed-Release Capsules
Medical News Today - Mylan Receives FDA Approval For Generic Version Of Prevacid Through Its Subsidiary Matrix Laboratories
Medical News Today - Aurobindo gets FDA nod for hypertension drug
Business Standard - FDA Approves Gloucester Pharmaceuticals' Istodax For Patients With Cutaneous T-cell Lymphoma
Medical News Today - FDA Approves Pennsaid Topical Solution
Reuters
- Ikano Therapeutics Receives Orphan Drug Designation for Epilepsy Drug
Business Wire - Daval International Awarded Orphan Drug Designation for Motor Neurone Disease Treatment
PharmiWeb
- ChemGenex's NDA for leukemia drug accepted for review by FDA
Trading Markets - Cequent files first IND application
Mass High Tech - Sol-Gel’s IND Application for Rosacea Accepted by FDA
Business Wire
- RECALL: Propofol & Liposyn
FDA Notice
E-mail This Newsletter to a Friend
PharmacyOneSource.com Privacy Policy
Pharmacy OneSource, 7780 Elmwood Ave. Ste #210 Middleton, WI 53562
Phone: (800) 654-8395
